诺和诺德:根据协议条款,公司将获得在所有适应症下独占开发和商业化Zaltenibart的全球权利
诺和诺德:根据协议条款,公司将获得在所有适应症下独占开发和商业化Zaltenibart的全球权利
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.